India  

EU close to fast-tracking COVID-19 treatment drug

Video Credit: Reuters Studio - Duration: 01:40s - Published
EU close to fast-tracking COVID-19 treatment drug

EU close to fast-tracking COVID-19 treatment drug

The head of the European Union's medicines agency, Guido Rasi, has said an initial authorization for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.

Joe Davies reports.

The European Union may give an initial green light in the coming days for the sale of the drug remdesivir as a COVID-19 treatment -- fast-tracking the drug to market -- and the latest in a tight global competition for resources to fight the pandemic.

It also comes after the United States angered the EU with its aggressive tactics in obtaining such resources.

The U.S. has yet to issue a similar approval for the drug.

Guido Rasi is head of the EU Medicines Agency: "Now, there is an ongoing rolling review in the EMA to support the CHMP's (human medicines committee) decision, and it might be that a conditional market authorization can be issued in the coming days, subject to the data that we've submitted and how the experts will deem those data robust enough to issue what I expect could be the conditional approval.

I don't see another kind of approval at this stage." The European Medicines Agency - or EMA - has already recommended the compassionate use of remdesivir, which allows a drug to be administered to patients even before its sale has been authorised.

Demand for remdesivir has been growing as there are currently no approved treatments or vaccines for COVID-19.

It's made by U.S. pharmaceutical company Gilead.

They're now negotiating long-term licenses with drugmakers in India and Pakistan to produce remdesivir for developing countries.

But it's unclear how soon sufficient amounts of the drug could be available to meet the world's need for a treatment.




You Might Like


💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Coronavirus: Spain's top military chief steps down after jumping queue for COVID vaccine [Video]

Coronavirus: Spain's top military chief steps down after jumping queue for COVID vaccine

Spain's top military chief has resigned after it was revealed he and other senior officers jumped the queue for a coronavirus vaccine.

Credit: Euronews English    Duration: 01:07Published
On GPS: Sanjay Gupta on Covid and his new book [Video]

On GPS: Sanjay Gupta on Covid and his new book

CNN’s Chief Medical correspondent joins Fareed to give a covid situation report and advice from his book “Keep Sharp” on how to take care of your brain.

Credit: Bleacher Report AOL    Duration: 07:44Published
White House's new Covid protocols make the workplace 'safer' [Video]

White House's new Covid protocols make the workplace 'safer'

Zeke Miller, the president of the White House Correspondents’ Association, says “things are different” at the White House now that Biden has taken charge. Masks have been mandated, Covid-19 testing has been expanded, and room capacity measures have been put in place. “All of those things make that workplace a little bit safer,” he says. Dr. Seema Yasmin and Karen Attiah also join the conversation.

Credit: Bleacher Report AOL    Duration: 05:24Published

European Union European Union Economic and political union of European states

Europe's week: Brussels eager for a new start after Biden inauguration [Video]

Europe's week: Brussels eager for a new start after Biden inauguration

"This new dawn in America is the moment we have been waiting for, for so long," said EU chief Ursula von der Leyen.

Credit: Euronews English    Duration: 06:59Published

'Unacceptable' vaccine delays cause frustration across European Union

European countries are growing increasingly frustrated with delays in the delivery of COVID-19 vaccinations.
Sky News

AstraZeneca to cut COVID-19 vaccine delivery to EU by 60%, reports

AstraZeneca will cut deliveries of the Oxford COVID-19 vaccine to the European Union by 60% in the first quarter of the year, according to Reuters news agency.
Sky News

European Medicines Agency European Medicines Agency Agency of the European Union

EU approves Moderna Covid-19 vaccine [Video]

EU approves Moderna Covid-19 vaccine

European health officials have recommended the use of the Moderna Covid-19vaccine. The European Medicines Agency (EMA) has recommended granting aconditional marketing authorisation for the jab for adults. British regulators– the Medicine and Healthcare products Regulatory Agency – are stillconducting a review on the vaccine.

Credit: PA - Press Association STUDIO    Duration: 01:28Published
EU's COVID-19 vaccine rollout suffering shortages and delays, says BioTech CEO [Video]

EU's COVID-19 vaccine rollout suffering shortages and delays, says BioTech CEO

The shortage is being partly blamed on the fact that the European Medicines Agency is yet to approve the Moderna and Oxford-Astrazeneca vaccines.

Credit: Euronews English    Duration: 02:13Published
Vaccinations will save lives, not vaccines, says EU Health Commissioner Stella Kyriakides [Video]

Vaccinations will save lives, not vaccines, says EU Health Commissioner Stella Kyriakides

Euronews speaks to the European Commissioner for Health, Stella Kyriakides, following Monday's approval of the Pfizer/BioNTech vaccine by the European Medicines Agency.

Credit: Euronews English    Duration: 02:18Published

Pakistan Pakistan Country in South Asia

Pakistan generated over 300 Twitter handles to disrupt farmers' rally: Delhi Police

Around 25,000 tractors from Uttar Pradesh and Uttarakhand will participate in the 'kisan parade' in the national capital on January 26
DNA

Terror groups in Pakistan switch to new messaging apps

The three new applications came to light after evidence was collected following encounters with terrorists or those who surrendered before the Army gave details..
IndiaTimes

Related news from verified sources

'HCQ can be used as preventive Covid treatment'

No major side-effects of Hydroxychloroquine (HCQ) have been found in studies in India and its use...
IndiaTimes - Published

Fujifilm COVID-19 drug research spills into June, dashing hopes of quick approval

Fujifilm Holdings Corp will continue research on Avigan into June, Japan's government said on...
Reuters India - Published

U.S. hospitals slash use of drug championed by Trump as coronavirus treatment

U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug...
Reuters India - Published


Related videos from verified sources

US Hospitals Cut Back On Use Of Hydroxychloroquine [Video]

US Hospitals Cut Back On Use Of Hydroxychloroquine

President Donald Trump promoted hydroxychloroquine, a malaria drug, as a COVID-19 treatment. According to Reuters, several studies suggest the drug isn’t effective against COVID-19 and creates..

Credit: Wochit     Duration: 00:32Published
SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients [Video]

SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients

SD company starts clinical trial for drug that could help prevent use of ventilators for COVID-19 patients

Credit: ABC 10 News | San Diego     Duration: 02:04Published
France Becomes the First Country to Ban Hydroxychloroquine as a Treatment for COVID-19 [Video]

France Becomes the First Country to Ban Hydroxychloroquine as a Treatment for COVID-19

France has become the first country in the world to ban the use of hydroxychloroquine as a treatment for COVID-19.

Credit: Veuer     Duration: 00:44Published